Osteoimmunopathology

Osteoimmunopathology-1

Francesco Chiappelli 2011 Evidence-Based Perspectives from Molecular Biology to Systems Biology The U.S. Patient Protection and Affordable Care Act (enacted on 23 March 2010) created a $1 billion program to award, on a competitive basis, federal subsidies to qualifying therapeutic discovery projects being conducted at small biomedical companies.

Continue reading →

Drugs for HER-2-positive Breast Cancer

Drugs for HER-2-positive Breast Cancer-1

Maria Sibilia l Christoph C. Zielinski l Rupert Bartsch l Thomas W. Grunt Editors 2011 Research over the last 2–3 decades in the fields of cell and molecular biology as ell as biomedicine has tremendously improved our understanding of the mechanisms of malignant transformation and progression. A lot of knowledge gained from these findings could already be […]

Continue reading →

BeadChip Molecular Immunohematology

BeadChip Molecular Immunohematology-1

Paul M. Ness Steve R. Sloan, JoAnn M. Moulds Editors 2011 Toward Routine Donor and Patient Antigen Profiling by DNA Analysis We have entered the era of molecular immunohematology, in which DNA is analyzed to predict red blood cell, leukocyte and platelet phenotypes. Molecular immunohematology is changing practice in blood donor centers, hospital blood banks, and reference laboratories.  

Continue reading →

Bacterial Lipopolysaccharides

Bacterial Lipopolysaccharides-1

Yuriy A. Knirel l Miguel A. Valvano Editors 2011 Structure, Chemical Synthesis, Biogenesis and Interaction with Host Cells The lipopolysaccharide (LPS) is the major component of the outer leaflet of the outer membrane of Gram-negative bacteria. It contributes essentially to the integrity and stability of the outer membrane, represents an effective permeability barrier towards external stress factors, and […]

Continue reading →